[6-K] NewGenIvf Group Ltd Current Report (Foreign Issuer)
Rhea-AI Filing Summary
NewGenIvf Group Limited is implementing a one-for-five reverse stock split of its issued and unissued Class A Ordinary Shares. The reverse split will be effective at 12:01 a.m. (ET) on December 1, 2025, and the shares will begin trading on a split-adjusted basis on Nasdaq the same day under the existing ticker NIVF.
The reverse split will reduce the number of outstanding Class A Ordinary Shares from 6,585,672 to approximately 1,317,135, so every five existing shares will be combined into one new share. No fractional shares will be issued; any shareholder who would otherwise receive a fraction will receive one whole post-split share instead. All outstanding options, warrants and other convertible securities will be adjusted by dividing the underlying share amount by five, rounded to the nearest whole share.
Positive
- None.
Negative
- None.
Insights
NIVF’s 1-for-5 reverse split consolidates shares without changing total equity.
NewGenIvf Group Limited is carrying out a one-for-five reverse stock split effective on
The company states that no fractional shares will be issued; instead, any holder who would have received a fraction gets one whole post-split share, which can slightly increase the final share count versus a pure 5:1 division. Options, warrants and other convertible securities will be adjusted by dividing their underlying share amounts by five and rounding to the nearest whole share, preserving economic terms on a split-adjusted basis.
The split becomes effective at 12:01 a.m. (ET) on